Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
22701 | 372 | 31.5 | 76% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
216 | 3 | NON SMALL CELL LUNG CANCER//LUNG CANCER//THORAC SURG | 51214 |
1422 | 2 | XRCC1//GEMCITABINE//ERCC1 | 7962 |
22701 | 1 | PEMETREXED//MULTITARGETED ANTIFOLATE//AFFILIATED JIANGSU CANC HOSP | 372 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PEMETREXED | authKW | 2201048 | 39% | 18% | 145 |
2 | MULTITARGETED ANTIFOLATE | authKW | 1369936 | 6% | 76% | 22 |
3 | AFFILIATED JIANGSU CANC HOSP | address | 1025004 | 9% | 39% | 32 |
4 | PEMETREXED DISODIUM | authKW | 738746 | 3% | 75% | 12 |
5 | LY231514 | authKW | 513015 | 3% | 63% | 10 |
6 | ALIMTA | authKW | 478335 | 3% | 45% | 13 |
7 | ALIMTAR | authKW | 246251 | 1% | 100% | 3 |
8 | CHEMOTHER Y | address | 244303 | 16% | 5% | 60 |
9 | CANTHARIDES SODIUM INJECTION | authKW | 164167 | 1% | 100% | 2 |
10 | IMMEDIATE ADMINISTRATION | authKW | 164167 | 1% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 9485 | 81% | 0% | 301 |
2 | Pharmacology & Pharmacy | 376 | 20% | 0% | 76 |
3 | Respiratory System | 158 | 6% | 0% | 22 |
4 | Integrative & Complementary Medicine | 4 | 1% | 0% | 2 |
5 | Medicine, Research & Experimental | 1 | 2% | 0% | 7 |
6 | Chemistry, Analytical | 0 | 2% | 0% | 8 |
7 | Dermatology | 0 | 1% | 0% | 3 |
8 | Urology & Nephrology | 0 | 1% | 0% | 4 |
9 | Biochemical Research Methods | 0 | 1% | 0% | 5 |
10 | Chemistry, Medicinal | 0 | 1% | 0% | 4 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | AFFILIATED JIANGSU CANC HOSP | 1025004 | 9% | 39% | 32 |
2 | CHEMOTHER Y | 244303 | 16% | 5% | 60 |
3 | CENT INDIANA CANC INDIAN OLIS | 82084 | 0% | 100% | 1 |
4 | CHIM ORGAN CNRSUMR 6239 | 82084 | 0% | 100% | 1 |
5 | CLIN BIOL SCI HEAD | 82084 | 0% | 100% | 1 |
6 | COMU | 82084 | 0% | 100% | 1 |
7 | DIPARTIMENTO GINECOL PERINATOL OSTETRICIA | 82084 | 0% | 100% | 1 |
8 | DISCIPLINE PHARMACOLBO | 82084 | 0% | 100% | 1 |
9 | GUNSAN WONKWANG UNIV HOSP | 82084 | 0% | 100% | 1 |
10 | GYNECOLOG ONCOL | 82084 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ASIAN PACIFIC JOURNAL OF CANCER PREVENTION | 73948 | 19% | 1% | 71 |
2 | SEMINARS IN ONCOLOGY | 17174 | 9% | 1% | 33 |
3 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 4457 | 5% | 0% | 20 |
4 | JOURNAL OF THORACIC ONCOLOGY | 3698 | 3% | 0% | 11 |
5 | LUNG CANCER | 2230 | 3% | 0% | 11 |
6 | CLINICAL CANCER RESEARCH | 2192 | 5% | 0% | 20 |
7 | INVESTIGATIONAL NEW DRUGS | 2047 | 2% | 0% | 8 |
8 | ANNALS OF ONCOLOGY | 1940 | 4% | 0% | 14 |
9 | CLINICAL BREAST CANCER | 1704 | 1% | 1% | 4 |
10 | ONCOLOGIST | 1327 | 2% | 0% | 6 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PEMETREXED | 2201048 | 39% | 18% | 145 | Search PEMETREXED | Search PEMETREXED |
2 | MULTITARGETED ANTIFOLATE | 1369936 | 6% | 76% | 22 | Search MULTITARGETED+ANTIFOLATE | Search MULTITARGETED+ANTIFOLATE |
3 | PEMETREXED DISODIUM | 738746 | 3% | 75% | 12 | Search PEMETREXED+DISODIUM | Search PEMETREXED+DISODIUM |
4 | LY231514 | 513015 | 3% | 63% | 10 | Search LY231514 | Search LY231514 |
5 | ALIMTA | 478335 | 3% | 45% | 13 | Search ALIMTA | Search ALIMTA |
6 | ALIMTAR | 246251 | 1% | 100% | 3 | Search ALIMTAR | Search ALIMTAR |
7 | CANTHARIDES SODIUM INJECTION | 164167 | 1% | 100% | 2 | Search CANTHARIDES+SODIUM+INJECTION | Search CANTHARIDES+SODIUM+INJECTION |
8 | IMMEDIATE ADMINISTRATION | 164167 | 1% | 100% | 2 | Search IMMEDIATE+ADMINISTRATION | Search IMMEDIATE+ADMINISTRATION |
9 | JAVANICA OIL EMULSION INJECTION | 164167 | 1% | 100% | 2 | Search JAVANICA+OIL+EMULSION+INJECTION | Search JAVANICA+OIL+EMULSION+INJECTION |
10 | PEG PEPTIDE PCL NANOPARTICLES | 164167 | 1% | 100% | 2 | Search PEG+PEPTIDE+PCL+NANOPARTICLES | Search PEG+PEPTIDE+PCL+NANOPARTICLES |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | WEI, GL , HUANG, XE , HUO, JG , WANG, XN , TANG, JH , (2013) PHASE II STUDY ON PEMETREXED-BASED CHEMOTHERAPY IN TREATING PATIENTS WITH METASTATIC GASTRIC CANCER NOT RESPONDING TO PRIOR PALLIATIVE CHEMOTHERAPY.ASIAN PACIFIC JOURNAL OF CANCER PREVENTION. VOL. 14. ISSUE 5. P. 2703-2706 | 40 | 83% | 3 |
2 | HUANG, XE , TIAN, GY , CAO, J , XU, X , LU, YY , WU, XY , LIU, J , SHI, L , XIANG, J , (2013) PEMETREXED AS A COMPONENT OF FIRST-, SECOND- AND THIRD-LINE CHEMOTHERAPY IN TREATING PATIENTS WITH METASTATIC LUNG ADENOCARCINOMA.ASIAN PACIFIC JOURNAL OF CANCER PREVENTION. VOL. 14. ISSUE 11. P. 6663-6667 | 37 | 84% | 6 |
3 | LU, YY , HUANG, XE , CAO, J , XU, X , WU, XY , LIU, J , XIANG, J , XU, L , (2013) PHASE II STUDY ON JAVANICA OIL EMULSION INJECTION (YADANZI (R)) COMBINED WITH CHEMOTHERAPY IN TREATING PATIENTS WITH ADVANCED LUNG ADENOCARCINOMA.ASIAN PACIFIC JOURNAL OF CANCER PREVENTION. VOL. 14. ISSUE 8. P. 4791-4794 | 32 | 89% | 8 |
4 | WU, Q , ZHAO, YB , SUN, ZH , NI, J , WU, YZ , SHAO, HH , QU, JW , HUANG, XE , (2013) CLINICAL APPLICATION OF ENDOSCOPIC INGUINAL LYMPH NODE RESECTION AFTER LIPOLYSIS AND LIPOSUCTION FOR VULVAR CANCER.ASIAN PACIFIC JOURNAL OF CANCER PREVENTION. VOL. 14. ISSUE 12. P. 7121-7126 | 34 | 83% | 4 |
5 | YAN, HA , SHEN, K , HUANG, XE , (2013) CLINICAL STUDY ON MANNAN PEPTIDE COMBINED WITH TP REGIMEN IN TREATING PATIENTS WITH NON-SMALL CELL LUNG CANCER.ASIAN PACIFIC JOURNAL OF CANCER PREVENTION. VOL. 14. ISSUE 8. P. 4801-4804 | 32 | 84% | 5 |
6 | CAO, J , HUANG, XE , LIU, J , WU, XY , LU, YY , (2013) COMPARISON OF EFFICACY AND TOXICITY OF FIRST LINE CHEMOTHERAPY WITH OR WITHOUT EPIRUBICIN FOR PATIENTS WITH ADVANCED STAGE SOFT TISSUE SARCOMA.ASIAN PACIFIC JOURNAL OF CANCER PREVENTION. VOL. 14. ISSUE 12. P. 7171-7177 | 37 | 65% | 2 |
7 | DENG, QQ , HUANG, XE , YE, LH , LU, YY , LIANG, Y , XIANG, J , (2013) PHASE II TRIAL OF LOUBO (R) (LOBAPLATIN) AND PEMETREXED FOR PATIENTS WITH METASTATIC BREAST CANCER NOT RESPONDING TO ANTHRACYCLINE OR TAXANES.ASIAN PACIFIC JOURNAL OF CANCER PREVENTION. VOL. 14. ISSUE 1. P. 413-417 | 25 | 78% | 16 |
8 | LIU, YC , ZHOU, SB , GAO, F , YIN, XX , ZHAO, Y , HUANG, XE , (2013) PHASE II STUDY ON BREAST CONSERVATIVE SURGERY PLUS CHEMO-AND RADIOTHERAPY IN TREATING CHINESE PATIENTS WITH EARLY STAGED BREAST CANCER.ASIAN PACIFIC JOURNAL OF CANCER PREVENTION. VOL. 14. ISSUE 6. P. 3747-3750 | 30 | 68% | 2 |
9 | YANG, L , HUANG, XE , XU, L , ZHOU, JN , YU, DS , ZHOU, X , LI, DZ , GUAN, X , (2013) ROLE OF MYH POLYMORPHISMS IN SPORADIC COLORECTAL CANCER IN CHINA: A CASE-CONTROL, POPULATION-BASED STUDY.ASIAN PACIFIC JOURNAL OF CANCER PREVENTION. VOL. 14. ISSUE 11. P. 6403-6409 | 36 | 56% | 2 |
10 | DAI, XZ , YIN, HT , SUN, LF , HU, X , ZHOU, C , ZHOU, Y , ZHANG, W , HUANG, XE , LI, XC , (2013) POTENTIAL THERAPEUTIC EFFICACY OF CURCUMIN IN LIVER CANCER.ASIAN PACIFIC JOURNAL OF CANCER PREVENTION. VOL. 14. ISSUE 6. P. 3855-3859 | 31 | 61% | 13 |
Classes with closest relation at Level 1 |